Cargando…
Successful treatment of a case of COVID-19 pneumonia following kidney transplantation using paxlovid and tocilizumab
BACKGROUND: Since its initial detection in 2019, coronavirus disease 2019 (COVID-19) pneumonia has rapidly spread throughout the world in a global pandemic. However, reports of COVID-19 pneumonia among patients following kidney transplantation have been limited and no uniform treatment guidelines fo...
Autores principales: | Chen, Qian, Niu, Yu-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10506020/ https://www.ncbi.nlm.nih.gov/pubmed/37727489 http://dx.doi.org/10.12998/wjcc.v11.i25.6012 |
Ejemplares similares
-
Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021) -
Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab
por: Guella, Adnane, et al.
Publicado: (2020) -
Monitoring tacrolimus toxicity following Paxlovid administration in a liver transplant patient
por: Maynard, Robert D., et al.
Publicado: (2023) -
Proxalutamide for the treatment of COVID‐19 rebound following Paxlovid treatment: Report of four cases and review of the literature
por: Yang, Da‐Wei, et al.
Publicado: (2023) -
The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022)